NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.
Episode 15 of the Patient Care Online Primary Viewpoints podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Primary Viewpoints podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today.
In episode 15, Dr Njira Lugogo discusses the prespecified exploratory on-treatment analysis of responses to tezepelumab using data from the phase 3 NAVIGATOR clinical trial, which she recently presented at the American Thoracic Society’s International Conference 2022, held May 13-18 in San Francisco.
Njira Lugogo, MD, is associate professor of internal medicine and director of the Asthma Program in the Division of Pulmonary and Critical Care Medicine at the University of Michigan.
Click here to subscribe to the Primary Viewpoints podcast. Be sure to leave a rating and review for the show. Thanks for listening!
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.
